TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Daito Pharmaceutical Co., Ltd. ( (JP:4577) ) is now available.
Daito Pharmaceutical Co., Ltd. reported a 5.6% increase in net sales for the nine months ending February 28, 2025, compared to the previous year. However, the company experienced a significant decline in profits, with operating profit down by 39.8% and ordinary profit by 34.9%. The financial results indicate challenges in maintaining profitability despite increased sales, which may impact the company’s strategic positioning and stakeholder confidence.
More about Daito Pharmaceutical Co., Ltd.
Daito Pharmaceutical Co., Ltd. is a company listed on the Tokyo Stock Exchange, operating in the pharmaceutical industry. The company is involved in the development, manufacturing, and distribution of pharmaceutical products, focusing on providing healthcare solutions in the Japanese market.
YTD Price Performance: 1.96%
Average Trading Volume: 34,705
Technical Sentiment Signal: Hold
Current Market Cap: Yen32.7B
Learn more about 4577 stock on TipRanks’ Stock Analysis page.